Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.
Partners In Health, Boston, MA.
JCO Glob Oncol. 2022 Jan;8:e2100369. doi: 10.1200/GO.21.00369.
Authorship gender disparities persist across academic disciplines, including oncology. However, little is known about global variation in authorship gender distribution.
This retrospective cross-sectional study describes the distribution of author gender as determined from the first name across variables such as authorship position (first, middle, and last), country region, and country income level. The 608 articles with 5,302 authors included in this analysis were published in the , from its inception in October 2015 through March 2020. Primary outcome measure was author gender on the basis of first name probabilities assessed by genderize.io. World Bank classification was used to categorize the country region and income level. Odds ratios were used to describe associations between female last authorship and representation in other authorship positions.
Although female authors were in the minority across all authorship positions, they were more under-represented in the last author position with 190 (32.1%) female, compared with 252 (41.4%) female first authors and 1,564 (38.1%) female middle authors. Female authors were most under-represented among authors from low-income countries, where they made up 21.6% of first authors and 9.1% of last authors. Of all the regions, sub-Saharan Africa and South Asia had the lowest percentage of female authors. Compared with articles with male last authors, those with female last authors had odds ratios (95% CI) of 2.2 (1.6 to 3.2) of having female first authors and 1.4 (0.9 to 2.1) of having 50% or more female middle authors.
There are wide regional variations in author gender distribution in global oncology. Female authors remain markedly under-represented, especially in lower-income countries, sub-Saharan Africa, and South Asia. Future interventions should be tailored to mitigate these disparities.
学术领域包括肿瘤学在内,作者的性别差异仍然存在。然而,对于作者性别分布的全球差异知之甚少。
本回顾性横断面研究描述了作者性别分布,根据作者姓名首字母确定作者性别,变量包括作者职位(第一、中、末位)、国家/地区和国家收入水平。本分析共纳入 608 篇文章,作者 5302 人,这些文章于 2015 年 10 月首次发表,至 2020 年 3 月期间发表。主要结局指标是根据 genderize.io 评估的首字母概率确定的作者性别。世界银行的分类用于对国家/地区和收入水平进行分类。比值比用于描述女性作为最后作者与其他作者职位的代表性之间的关联。
尽管所有作者职位中的女性作者都处于少数地位,但她们在最后作者职位中代表性严重不足,女性最后作者 190 人(32.1%),女性第一作者 252 人(41.4%),女性中间作者 1564 人(38.1%)。女性作者在低收入国家中代表性严重不足,在这些国家中,她们占第一作者的 21.6%,占最后作者的 9.1%。在所有地区中,撒哈拉以南非洲和南亚地区的女性作者比例最低。与有男性最后作者的文章相比,有女性最后作者的文章中,女性第一作者的比值比(95%CI)为 2.2(1.6 至 3.2),女性中间作者占 50%或更多的比值比为 1.4(0.9 至 2.1)。
全球肿瘤学领域的作者性别分布存在广泛的地区差异。女性作者的代表性仍然明显不足,特别是在低收入国家、撒哈拉以南非洲和南亚地区。未来的干预措施应针对这些差异进行调整。